On September 30, 2024, Safety Shot, Inc., a Delaware-based wellness and dietary supplement company, announced a significant commercial milestone. The company's flagship product, Safety Shot, a 4 oz. beverage designed to reduce blood alcohol content, will be available at over 300 7-Eleven stores in the Chicago area. This strategic move is timed to coincide with the fourth quarter, which traditionally sees a spike in alcohol sales due to holiday festivities. Safety Shot's CEO, Jarrett Boon, highlighted the importance of this distribution partnership with 7-Eleven, emphasizing the potential for increased visibility and sales during the peak season for alcohol consumption. The product will be prominently placed on countertops and priced at $5.99 for one or $10 for two. Safety Shot, Inc. is also planning to expand its business-to-business sales throughout 2024, targeting distributors, retailers, restaurants, and bars. The company's press release also contained forward-looking statements regarding its product development and commercialization plans.

On September 30, 2024, Safety Shot, Inc., a Delaware-based wellness and dietary supplement company, announced a significant commercial milestone. The company's flagship product, Safety Shot, a 4 oz. beverage designed to reduce blood alcohol content, will be available at over 300 7-Eleven stores in the Chicago area. This strategic move is timed to coincide with the fourth quarter, which traditionally sees a spike in alcohol sales due to holiday festivities. Safety Shot's CEO, Jarrett Boon, highlighted the importance of this distribution partnership with 7-Eleven, emphasizing the potential for increased visibility and sales during the peak season for alcohol consumption. The product will be prominently placed on countertops and priced at $5.99 for one or $10 for two. Safety Shot, Inc. is also planning to expand its business-to-business sales throughout 2024, targeting distributors, retailers, restaurants, and bars. The company's press release also contained forward-looking statements regarding its product development and commercialization plans.